MRPL13 and neoplasm: By comparing the mutations of patients with high and low MRPL13 expression, it is concluded that MRPL13 may make tumor cells escape the cell cycle checkpoint, avoid apoptosis and aging, and gain abnormal proliferation ability by affecting the classical TP53 mutation.